BERNARDO, ALFONSO
 Distribuzione geografica
Continente #
AS - Asia 170
EU - Europa 127
NA - Nord America 105
SA - Sud America 22
AF - Africa 4
Totale 428
Nazione #
US - Stati Uniti d'America 93
SG - Singapore 87
RU - Federazione Russa 62
CN - Cina 43
BR - Brasile 18
DE - Germania 18
IT - Italia 18
VN - Vietnam 14
HK - Hong Kong 9
CA - Canada 8
GB - Regno Unito 8
FI - Finlandia 6
KR - Corea 6
IN - India 5
AR - Argentina 3
AT - Austria 3
FR - Francia 3
BD - Bangladesh 2
CI - Costa d'Avorio 2
NL - Olanda 2
SE - Svezia 2
BE - Belgio 1
CU - Cuba 1
DO - Repubblica Dominicana 1
ES - Italia 1
ID - Indonesia 1
IQ - Iraq 1
JM - Giamaica 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
PE - Perù 1
PL - Polonia 1
SD - Sudan 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 428
Città #
Singapore 45
Hefei 21
Moscow 20
Munich 13
Chandler 12
Beijing 11
Ashburn 9
Hong Kong 9
Santa Clara 9
Naples 7
Turku 6
Los Angeles 5
Seoul 5
Dong Ket 4
Ho Chi Minh City 4
New York 4
Formia 3
Kochi 3
Montreal 3
Redondo Beach 3
Toronto 3
Amsterdam 2
Araraquara 2
Catanzaro 2
Frankfurt am Main 2
Hanoi 2
London 2
L’Aquila 2
Manchester 2
Phoenix 2
Pune 2
Rio de Janeiro 2
Seattle 2
Stockholm 2
Ankara 1
Antonivka 1
Arequipa 1
Atlanta 1
Belford Roxo 1
Belo Horizonte 1
Belvedere 1
Bexley 1
Birmingham 1
Boardman 1
Boston 1
Brooklyn 1
Brussels 1
Bryansk 1
Buffalo 1
Bắc Giang 1
Cachoeirinha 1
Calgary 1
Can Tho 1
Caserta 1
Caxias do Sul 1
Cerquilho 1
Cleveland 1
Contagem 1
Cuiabá 1
Deiva Marina 1
Des Moines 1
Dhaka 1
Düsseldorf 1
Edinburgh 1
Elk Grove Village 1
Erbil 1
Greensburg 1
Havana 1
Ituiutaba 1
Kalamazoo 1
Kenitra 1
Khartoum 1
Lawrence 1
Leawood 1
Mandeville 1
Millbury 1
Nuremberg 1
Paraisópolis 1
Paripiranga 1
Passo Fundo 1
Ponta Grossa 1
Puerto Rico 1
Rafael Castillo 1
Sant'Agnello 1
Santo Domingo 1
Sapucaia do Sul 1
Seongnam-si 1
São José da Laje 1
Tampa 1
Tashkent 1
Tlaquepaque 1
Vancouver 1
Villa Eduardo Madero 1
Warsaw 1
Totale 285
Nome #
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial 117
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 115
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer 107
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054] 96
Totale 435
Categoria #
all - tutte 1.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 3 0 1 4
2021/20229 0 0 1 0 0 0 1 0 0 1 3 3
2022/202332 1 2 1 4 2 3 0 4 1 3 8 3
2023/202423 1 6 3 4 2 2 0 2 0 0 2 1
2024/2025159 6 7 0 3 7 10 14 10 7 14 61 20
2025/2026204 39 28 34 37 58 8 0 0 0 0 0 0
Totale 435